Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

@article{Rothman2001AmphetaminetypeCN,
  title={Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin},
  author={R. Rothman and M. Baumann and C. Dersch and D. Romero and K. Rice and F. Carroll and J. Partilla},
  journal={Synapse},
  year={2001},
  volume={39}
}
  • R. Rothman, M. Baumann, +4 authors J. Partilla
  • Published 2001
  • Psychology, Medicine
  • Synapse
    • A large body of evidence supports the hypothesis that mesolimbic dopamine (DA) mediates, in animal models, the reinforcing effects of central nervous system stimulants such as cocaine and amphetamine. The role DA plays in mediating amphetamine‐type subjective effects of stimulants in humans remains to be established. Both amphetamine and cocaine increase norepinephrine (NE) via stimulation of release and inhibition of reuptake, respectively. If increases in NE mediate amphetamine‐type… CONTINUE READING
    View on Wiley
    lycaeum.org
    826 Citations
    Highly Influencial Citations
    58
    Background Citations
    383
    Methods Citations
    44
    Results Citations
    27
    826 Citations
    Citation Type

    Citation Type

    Behavioral and neurochemical effects of amphetamine analogs that release monoamines in the squirrel monkey
    • 18
    • PDF
    The Effects of Amphetamine and Methamphetamine on the Release of Norepinephrine, Dopamine and Acetylcholine From the Brainstem Reticular Formation
    • 9
    • Highly Influenced
    • PDF
    Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys.
    • 17
    • PDF
    Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats
    • 9
    • Highly Influenced
    • PDF
    Noradrenergic and dopaminergic effects of (+)‐amphetamine‐like stimulants in the baboon Papio anubis
    • 42
    Dopamine/serotonin releasers as medications for stimulant addictions.
    • 38
    Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction.
    • 67
    Effects of “Legal X” Piperazine Analogs on Dopamine and Serotonin Release in Rat Brain
    • 72
    • PDF
    Pharmacology, neurobiology and neurotoxicity of methamphetamine
    • 1
    • PDF
    Development of a Rationally Designed, Low Abuse Potential, Biogenic Amine Releaser That Suppresses Cocaine Self-Administration
    • 83

    References

    SHOWING 1-10 OF 78 REFERENCES
    Neurochemical neutralization of methamphetamine with high‐affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse
    • 80
    • PDF
    Biological and behavioral responses to d-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers
    • 32
    Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data
    • 100
    Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers
    • 108
    High Dose Pimozide Does Not Block Amphetamine-Induced Euphoria in Normal Volunteers
    • L. Brauer, H. Wit
    • Psychology, Medicine
    • Pharmacology Biochemistry and Behavior
    • 1997
    • 136
    The interaction of cocaine with serotonin dorsal raphe neurons. Single-unit extracellular recording studies.
    • K. Cunningham, J. Lakoski
    • Chemistry, Medicine
    • Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
    • 1990
    • 124
    Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man
    • 902
    Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans
    • 81
    Doses of GBR12909 that suppress cocaine self‐administration in non‐human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans
    • 55
    Phentermine and fenfluramine. Preclinical studies in animal models of cocaine addiction.
    • 22